Ref No. |
sts al ap |
cf |
Drop outs |
Up / down rg |
Pk |
sd oc |
cr |
sts sn rd |
7 |
1-tailed paired Student t |
Y |
NM |
βG: inc |
M-010 PM-07 CI-08 |
IL-1β sign inc for Mo- O5 to O10 for PM-O6 to 010 For CI-04, 06, 07, 09, 010 & dec at O2 for Mo, PM, CI |
stronger F cause higher levels of IL-1β & βG |
βG inc for Mo- 07 to 010 PM-07, 08, 010 CI-06, 07, 010 & dec at O2 for Mo, PM, CI |
8 |
ANOVA, paired t test |
Y |
NaM |
Inc at 2h, bas in 7d |
2h |
Inc MPO in saliva at 2h, B in 7d |
+ve cr of lvl in GCF & saliva |
Inc at 2h |
9 |
(ANOVA) Kolmogorov-Smirnov test, Paired-samples test |
Y |
N |
Inc |
2wk |
NM |
NM |
In cns F: Lvl pk at 2wk In gradually inc F: Lvl pk at 3wk |
10 |
Kolmogorov and Smirnov (ANOVA) & Tukey’s post-hoc test |
Y |
N |
Inc |
14d |
GCF vol inc from 0 - 21d Sn inc at 14d |
Exp si; lvl inc on 14d cr with pk in GCF vol |
Exp si; pk at 14d |
11 |
Paired t test Pearson’s cr |
Y |
N |
LDH inc at 2, 3& 4 wk(100 g) & 1, 2 & 3wk (150 g). AST inc at 4 & 5wk (100 g) & 3 & 4wk (150 g). TRAP inc at 5wk (100 g) |
AST: 1wk TRAP: 2wk ALP: 5wk |
In saliva:AST inc at 5wk, TRAP at 2wk, ALP at 1 to 5wk |
Weak cr b/w enz quantity & activity |
LDH inc at 2, 3 & 4 wk (100 g) & 1, 2 & 3wk (150 g). AST inc at 4 & 5wk (100 g) & 3 & 4wk (150 g) TRAP inc at 5wk (100 g) |
12 |
Friedman test for intergp & intragp, Wilcoxon test for related samples, Kruskal-Wallis test for independent samples in both gps |
Y |
N |
inc |
2h |
minm & severe crw: inc from 0 at 2h, 7d, 14d in saliva |
No cr of crw with change in MPO |
At 2h, 7d sn inc from B & 14d |
13 |
Intra gp: Friedman’s test, Wilcoxon test Inter gp: Mann-Whitney U test, Pearson’s test |
Y |
N |
inc |
MMP9: 8h MMP9/NGAL: 72h |
TSP1: inc from B at 8h to 72h, dec at 1wk |
Strong & sn cr b/w MMP9/NGAL & TSP1 in IxT |
MMP9: inc from B at 4h, 8h, 1wk, 2wk. MMP9/NGAL: inc from B at 8h,24h, 72h |
14 |
Intergp: Mann Whitney U test. Intra gp: Students unpaired t-test |
Y |
N |
Inc |
ACP: 3d ALP, AST: 15d |
NM |
NM |
Inter gp; ACP: pk at 3d ALP, AST: pk at 15d Intra gp: ACP, ALP, AST higher in Mx I than Mo |
15 |
SAS version 9.2 proc mixed subroutine |
Y |
N |
No sts sn change |
NM |
Exp si: in Ad, IL-1/1L-1RA dec in 3wk aftr 1st wi lig ado, RANKL/OPG pk at 6wk aftr 1st rect wi lig |
NM |
b/w Exp & cT; no sts sn change B/w Ad & adol: no sts sn diff |
16 |
MedCalc software Intergp: Student’s t-test, ANOVA. |
Y |
N |
SL+ NiTi wi: inc SL+ thrm wi: dec |
No sts sn change |
Visual pl scr dec sts sn |
NM |
No sts sn change b/w Exp & cT or within each gp |
17 |
Luminex analysis |
Y |
N |
MMP1,3:inc, pk at 24h MMP8: pk at 14d |
24h |
NM |
NM |
No sts sg diff b/w comp & tn, MMP1, 3: inc, pk at 24h MMP8: pk at 14d |
18 |
Paired non-parametric Kruskall-Wallis. Spearman Rank Sum anal |
Y |
NM |
Inc |
Exp-TIMP, MMP-9:4h cmp: TIMP-1, MMP-9:4h, TIMP-2: 7d |
+ve cr of GCF vol & PI at 0 at tn, cmp +ve cr of TNF-α, IL-1β, IL-8, GM-CSF to speed of OTM at 4h in Exp cr of IL-1β, IL-8, TNF-α inc to if at 0 at cmp |
+ve cr of MMP-9 & TIMP to speed of OTM at 4h in Exp |
TIMP1 & 2, MMP-9 inc at 4h in Exp |
19 |
GraphPad®Instat, ANOVA, Friedman |
Y |
NM |
Inc |
14d, 21d |
NM |
NM |
Inc at 7, 14, 21d |
20 |
Friedman, Mann-Whitney |
Y |
NM |
Inc |
1h |
GCF vol higher in cmp than tn at 21d |
NM |
MMPs inc at 1h, dec at 24h |
21 |
ANOVA |
|
NM |
Cp: dec Cys:inc |
1d |
GCF vol inc in 1d, dec at 1m |
-ve cr in Cp & Cys Lvl |
Cp;dec at 1d, inc to B in 1m Cys;inc in 1d, dec to B in 1 |
22 |
ANOVA |
Y |
NM |
Inc |
MMP1-1h MMP2-1h,8h |
NM |
NM |
Inc in MMP1 (tn) -1h-3h, (cmp) -1h Inc in MMP2 (tn) - 1h, (comp)-8h |
23 |
Mann-Whitney U-tests |
N |
NM |
Inc at 24h at Ix t >cT |
24h |
GCF vol no sn diff at 24h |
NM |
Inc at 24h |
24 |
ANOVA &LSD |
Y |
NM |
Inc |
14d |
NM |
NM |
Inc in ALP -7, 14 at Ms & D |
25 |
Friedman test |
Y |
NM |
Dec |
I d |
Dpd, osteocalcin dec |
NM |
Dec from 0 to 28 d, inc on 7d |
26 |
Friedman and Bonferroni-corrected, Wilcoxon paired signed rank tests |
Y |
NM |
Inc |
14d |
NM |
NM |
ct gp greater than Ag gp on 14 d & 21d |
27 |
NM |
Y |
NM |
Lvl of MMP-8 inc in Ix t>c |
NM |
NM |
NM |
Lvl of MMP-8 inc 12 times in Ix t>c |
28 |
Friedman & Bonferroni-corrected, Wilcoxon paired signed rank tests |
Y |
NM |
Inc |
28d |
Aa colonization inc sn on 28d in ExpT & ct gp |
NM |
Inc at 28d in Ix T as compd to Ct T & Ag T |
29 |
Friedman & Bonferroni-corrected, Wilcoxon paired signed rank tests |
Y |
NM |
Inc |
tn:7d cmp:7&14d |
NM |
NM |
AST: inc in Ix T & ct T as compd to Ag T, inc in IxT as compd to ctT on tn si on 14d & on cmp on 7d & 14d, inc in IxT on cmp than tn on 7d |
30 |
Mann Whitney U-test |
Y |
N |
Inc |
24h |
|
NM |
CpB higher at 24h at IxT |
31 |
Bonferroni-corrected, 1-way repeated measures ANOVA, paired Student t test |
Y |
NM |
Inc |
14d |
NM |
NM |
Sign inc on both M & D at 1,2,3,4 wks |
32 |
One-tailed paired Student t test |
Y |
N |
Inc |
βG -25d IL-1β- |
sn inc in IL-1β level at 4d &19d to 60d AL |
NM |
inc in βG at 25d to 60d AL |
33 |
Student’s t test |
Y |
N |
IL-1β, IL-6, TNF-α, EGF, β2-µG |
inc |
24h |
Intra-grp in Exp: IL-1β inc at 24h > BS,IL-6 inc at 24h > BS or 168h,TNF-α inc at 24h > BS or 168h, EGF inc at 24h>BS Intergrp btw cont & Exp: IL-1β inc in Exp>cont at 24h, Mean IL-6 in Exp >ant cont, TNF-αin Exp at 24h> ant cont, EGF in Exp at 24hr> ant cont |
NM |
Ref No. |
sts al ap |
cf |
Drop outs |
Up / down rg |
Pk |
sd oc |
cr |
sts sn rd |
34 |
ANOVA |
Y |
NM |
Inc |
7d |
TNF-α in D & Ms sites of TT sn higher than both sites of c, also >.B, inc sn at 1 h & 24h. IL-10 dec during Exp period at c & TT |
NM |
TRAP5b Level in D & Ms sites of TT were sn higher than that at both sites of cT compd with B values, inc was sn at 1 h & 24h. |
35 |
Shapiro-Wilk test |
Y |
NM |
inc |
100g gp-TRAP-3wk 150g gp-ALP & TRAP -5wk |
NM |
NM |
In 100 g gp, TRAP sn inc in 3-5 wk compd to TRAPB. ALP & AST slightly inc. In 150 g gp, ALP & TRAP slightly inc compd with their B. AST sn inc in 5 wk. |
36 |
Student’s paired t test |
Y |
NM |
Inc |
M:4wk D:1.5N-2wk |
NM |
NM |
LDH at Ms site in 1.0 N &1.5 N gp, inc sn on 4th wk. At D site, LDH with 1.5 N was higher than 1.0 N throughout 5 wk of TM. LDH with 1.5 NF inc at both Ms (wk 2) & D site (wk 3) with sn diff to 1.0 N F |
37 |
Kruskal Walis test. |
Y |
NM |
TRAP inc in 150g F: Ms site peak 3wk, D site Pk 4wk den dec 100g F: Ms site 2wk Pk den dec, D site 5wk 4wk: Lvl in 150g> 100g F (D site) 5wk: Lvl in 100g>150g F (Dsite) |
150g: D site -4wk, Ms site-3wk 100g:D site-5wk. Ms site-2wk |
Rate of OTM at 150g>100g |
150g F at 3 & 4wk>100g f, +ve cr of Lvl of TRAP & rate of OTM |
150g gp, Ms si: inc at 3wk>BS At D si: inc at 4k>BS TRAP at 150 gm>100gm F at 4wk (D site) |
38 |
Paired sample t-test |
Y |
NM |
inc, pk at 2wk, at D >Ms- 1wk |
Ms, D Si: 2wk |
NM |
NM |
Inc at 1wk, 2wk from Bas |
39 |
Paired sample t-test |
Y |
NM |
Dec: 1wk,4wk on Ms, D si |
4wk |
NM |
-ve cr of amt of OTM & Lvl of ALP |
Dec at 4wk |
40 |
Wilcoxon signed rank test |
Y |
NM |
Inc: at 1wk,4wk, stabilised |
4wk |
NM |
NM |
Inc at 1wk, 4wk, At D si>Ms si |
41 |
Wilcoxon signed rank test |
Y |
NM |
Inc at 1wk, dec in next 3wk |
1wk |
N |
NM |
Pk at 1wk at Ix T>cT |
42 |
unpaired and paired t-test |
Y |
NM |
Inc at archwi >self lig site, inc at 1wk |
1wk |
Bac count in archwi>self lig |
+ve cr in self lig & AST Lvl |
Inc at archwi >self lig |
43 |
ANOVA, paired t-test using SPSS |
Y |
NM |
ALP, ACP inc at 14d, 28d, ALP at Ms>D, ACP inc in Ms &D |
ALP, ACP : 14d |
NM |
NM |
ALP, ACP inc, ALP inc more on M si |
44 |
ANOVA, Student's t-test |
Y |
NM |
ALP dec, D of C > Ms of 2nd PM on 1, 7, 14, 21, 28d |
Dec |
NM |
NM |
Dec at D of C > Ms of 2nd PM on 1, 7, 14, 21, 28d |
45 |
Friedman test followed by a Bonferroni-corrected Wilcoxon paired signed rank test |
Y |
Y |
ALP inc in 3m, 6m |
Inc |
PD with ALP actv |
+ve corr of ALP lvl with time at tn si |
ALP at 3m, 6m > cT |
46 |
ANOVA,Tukey’s HSD Post-Hoc test, Mann-Whitney U-test |
Y |
NM |
ALP inc 14d, 28d |
28d |
NM |
NM |
ALP at Ms si of TT>CT at 14d, 28d At Ms si>Dsi at 14d, 28d |
47 |
ANOVA, Independent Samples t-test, Mann- Whitney U-test |
Y |
NM |
ACP inc both Ms & D si D si>M si at 7d, 21d |
21d |
NM |
NM |
D si>M si at 7d, 21d TT>cT at 7d, 21 d at Dsi |
48 |
ANOVA,Tukey HSD |
Y |
NM |
LDH inc at TT>cT 7d, 14d,21d |
28d |
NM |
NM |
LDH inc frm 7d-14d at TT, TT>cT at 7, 14, 21d |
49 |
Friedman & Bonferroni-corrected Wilcoxon paired signed rank tests |
Y |
N |
AST inc from BS in T/t gp from BS to 2wk followed by dec Inc in CC gp from BS to 1wk followed by dec AST level in comp >tn on 1wk |
14d |
GCF flow in T/t=CC>AC gp |
+ve correl of mechanical stress to AST levels, T/t>CC |
sn inc in T/t &CC vs AC gp: 1, 2, 3, 4w sn inc in T/t vs CC gp: 1, 2wk AST level in comp >tn on 1wk |
50 |
One-way ANOVA was used for multiple group and Student t test for group-wise comparisons |
Y |
N |
inc in ALP b/w 21d & 28d :of 200% in active TB gp, of 260% in Rt screw gp |
TB: 21d Rt screw:28d |
Space closure rate, root resorption, Rt, anchorage loss with Hycon screw were assessed |
+ve correl of ALP in Hycon screw gp with actvn of screw |
Sign diff in ALP on 21d & 28d b/w TB & Rt screw gp |
51 |
independent t tests, _2 tests, or Mann-Whitney, intraexaminer reliability - concordance correlation coefficient (CCC) & Bland-Altman method |
N |
Y |
MMP8,9, MMP8/TIMP1, MMP9/TIMP1, resistin at BS>1h>1wk>compl of Aln CRP, MPO, TIMP, RANKL inc from BS to compl of Aln Adiponectin BS<1h<1wk>compl of Aln Leptin dec from BS to compl of Aln |
NM |
resistin at BS>1h>1wk>compl of Aln CRP, RANKL inc from BS to compl of Aln Adiponectin BS<1h<1wk>compl of Aln Leptin dec from BS to compl of Aln |
Mediators correl with Aln rate- MPO, RANKL, Leptin, Resistin |
MPO at BS<1h<1d<compl of Aln |
52 |
Fisher’s PLSD followed by post hoc, Bonferroni- Dunn |
Y |
N |
ALP on cmp site: 0>2wk>4wk<1y tn site: 0<2wk<4wk<1y |
tn site: 1y cmp site: before actvn |
NM |
+ve correl of intermolar distance with ALP level in tn site |
tn site:0 (before actvn) < 4wk, 0<1y cmp site: 0>4wk, 0<1y, 2wk>4wk |
53 |
paired & unpaired ‘t’ test and ANOVA. |
Y |
N |
MPO inc from BS to 2h in HANT, SE, MSSS gp |
2h |
NM |
MPO in HANT>SE>MSSS |
sn diff in MPO b/w SE & MSSS :2h, 2wk, b/w HANT & MSSS:2h, b/w SE & MSSS:1wk |
54 |
Chi-square Student’s t-test, and one-way analysis of variance |
Y |
N |
MPO inc from BS to 2h in HANT, SE, MSNiTi gp, HANT>SE & MS NiTi:2h |
2h |
NM |
NM |
sn diff b/w SE & MSNiTi: 2h, 1, 2wk, b/w HANT & MSNiTi:2h |
55 |
Independent & paired sample t- test |
Y |
N |
AST inc from BS to 1wk, then dec in Exp gp |
1wk |
NM |
NM |
Levels greater in Exp than Cn gp at 1, 2, 3, 4wk |